Abstract
A new method was developed for synthesis of 1,2,4-triazole-3-carboxylates 5a-p and 6 from nitrilimines 3a-p through amination and heterocyclization two-steps reactions. All of 1,2,4-triazole-3-carboxylates 5 and 6 were characterized by spectroscopy technique. Based on the SAR study of anti-inflammation activity, most of these compounds showed potential anti-inflammatory activity on NO inhibition in LPS-induced RAW 264.7 cells (IC50 < 7.0 µM) compared with Celecoxib and Indomethacin. Several potential compounds 5b-h, 5j, 5l, 5n, and 5o were subjected to in vitro cyclooxygenase COX-1/COX-2 inhibition assays. Compound 5d showed extraordinary COX-2 inhibition (IC50 = 17.9 nM) and the best selectivity (COX-1/COX-2 = 1080). Furthermore, 5 mg/kg compound 5d exhibited better in vivo anti-inflammation and gastric protection results compared to 10 mg/kg Indomethacin. Docking experiments of 5d into COX-2 binding pocket have been evaluated. Following the bioactivities experimental data, the potential drug candidate 5d, significantly exhibited better anti-inflammatory effect than Indomethacin.
Keywords:
1,2,4-Triazole; Anti-inflammation; COX-2 inhibitor; Heterocyclization.
Copyright © 2020 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis
-
Anti-Inflammatory Agents, Non-Steroidal / chemistry
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
-
Carboxylic Acids / chemical synthesis
-
Carboxylic Acids / chemistry
-
Carboxylic Acids / pharmacology*
-
Carrageenan
-
Cell Survival / drug effects
-
Cells, Cultured
-
Cyclooxygenase 2 / metabolism
-
Cyclooxygenase 2 Inhibitors / chemical synthesis
-
Cyclooxygenase 2 Inhibitors / chemistry
-
Cyclooxygenase 2 Inhibitors / pharmacology*
-
Dose-Response Relationship, Drug
-
Drug Design*
-
Edema / chemically induced
-
Edema / metabolism
-
Edema / pathology
-
Gastric Mucosa / drug effects
-
Gastric Mucosa / metabolism
-
Gastric Mucosa / pathology
-
Humans
-
Lipopolysaccharides / antagonists & inhibitors
-
Lipopolysaccharides / pharmacology
-
Male
-
Mice
-
Mice, Inbred ICR
-
Models, Molecular
-
Molecular Docking Simulation*
-
Molecular Structure
-
Nitric Oxide / antagonists & inhibitors
-
Nitric Oxide / biosynthesis
-
RAW 264.7 Cells
-
Recombinant Proteins / metabolism
-
Structure-Activity Relationship
-
Triazoles / chemical synthesis
-
Triazoles / chemistry
-
Triazoles / pharmacology*
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Carboxylic Acids
-
Cyclooxygenase 2 Inhibitors
-
Lipopolysaccharides
-
Recombinant Proteins
-
Triazoles
-
1,2,4-triazole
-
Nitric Oxide
-
Carrageenan
-
Cyclooxygenase 2